• Rewiring Cancer Metabolism: FK866 and the Future of NAMPT In

  2026-05-21

  Explore how FK866 (APO866), a next-generation NAMPT inhibitor, is redefining translational approaches to hematologic cancers and beyond. This article provides mechanistic insight, strategic trial design guidance, and protocol recommendations, while contextualizing recent advances in combinatorial therapies and biomarker-driven targeting. Drawing from emerging evidence, we chart a vision for metabolic targeting that avoids common pitfalls and identifies actionable frontiers for translational scientists.

• Optimizing hiPSC-Derived Platelet Production with Small Mole

  2026-05-20

  This study introduces an optimized protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs), integrating higher embryoid body (EB) cell input, refined serum-free media, and small molecule modulators. The approach significantly improves megakaryocyte and platelet yield, reduces costs, and demonstrates robust platelet function, offering a promising avenue for scalable platelet manufacturing.

• Lactate-Driven HMGB1 Lactylation and Release in Sepsis Macro

  2026-05-20

  Yang et al. uncover how extracellular lactate promotes both lactylation and acetylation of HMGB1 in macrophages during polymicrobial sepsis, driving its exosomal release and exacerbating endothelial permeability. This mechanistic insight highlights lactate signaling as a potential therapeutic target and has direct implications for experimental design in studies of post-translational modifications.

• SAR131675: Redefining VEGFR-3 Inhibition for Anti-Lymphangio

  2026-05-19

  Explore how SAR131675, a potent VEGFR-3 inhibitor, advances anti-lymphangiogenic research with unmatched selectivity and mechanistic clarity. This article analyzes new evidence on disease modeling and practical assay decisions, offering insights distinct from standard reviews.

• Sulfo-NHS-Biotin for Precision Protein Labeling: Workflow &

  2026-05-19

  Sulfo-NHS-Biotin stands apart for selective, membrane-impermeant protein biotinylation—ideal for cell surface profiling and high-throughput screening. This article demystifies its optimal use, workflow integration, and troubleshooting, drawing on innovations in single-cell nanovial assays and best practices from leading research.

• Clathrin-Mediated Entry of GCRV: Inhibitor Analysis Advances

  2026-05-18

  Wang et al. (2018) conducted a systematic inhibitor analysis to elucidate how type III grass carp reovirus (GCRV104) enters host cells. Their findings demonstrate that clathrin-mediated, pH-dependent endocytosis is essential for viral entry, with PI3K inhibition by Wortmannin significantly blocking infection. This work clarifies viral entry mechanisms and guides targeted antiviral research.

• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Precise

  2026-05-18

  Sulfo-Cy3 NHS Ester is the hydrophilic fluorescent dye of choice for sensitive, high-efficiency labeling of challenging proteins and peptides, offering unmatched water solubility and reduced quenching. Its robust performance streamlines workflows in vascular and cell biology research, outperforming traditional dyes, especially for low-solubility targets.

• Applied Workflows with SAR131675: Selective VEGFR-3 Inhibito

  2026-05-17

  SAR131675, a highly selective VEGFR-3 inhibitor, enables rapid dissection of VEGFC-driven pathways in fibrosis, lymphangiogenesis, and tumor biology with exceptional specificity. This article breaks down reproducible assay workflows, troubleshooting tactics, and key innovations—anchored by the latest NASH fibrosis research.

• Early Life Adversity Impairs Innate Defensive Behaviors via

  2026-05-16

  Tan et al. (2026) provide direct evidence that social deprivation during early postnatal life disrupts visually evoked innate defensive behaviors in mice by downregulating oxytocin receptor signaling in the superior colliculus. These findings clarify a key neurobiological mechanism linking early adversity to impaired threat detection and suggest new avenues for targeted intervention.

• Sulfo-NHS-LC-Biotin: Technical Guide for Cell Surface Biotin

  2026-05-15

  Sulfo-NHS-LC-Biotin enables selective, stable biotin labeling of primary amines on cell surface proteins under fully aqueous conditions, supporting workflows that require covalent immobilization or detection via biotin-avidin systems. It is not suitable for intracellular or reversible labeling applications due to its membrane-impermeable and irreversible chemistry.

• IRE1 Activation Restores Proteostasis in Misfolded GABAAR Va

  2026-05-15

  This study demonstrates that selective pharmacological activation of the IRE1/XBP1s pathway can rescue trafficking-deficient GABAA receptor (GABAAR) α1 variants implicated in genetic epilepsies. The findings reveal a targeted approach to enhancing protein folding and surface expression, offering mechanistic insights and translational potential for disorders linked to ER proteostasis defects.

• Strategic PI3K Activation: 740 Y-P for Translational Discove

  2026-05-14

  This thought-leadership article explores the mechanistic value and translational potential of 740 Y-P, a potent PI 3-kinase activator from APExBIO. It discusses how 740 Y-P enables precision modulation of the PI3K/AKT pathway in models of oxidative stress, vesicular trafficking, and neuronal survival. The article synthesizes current evidence, including insights from capsaicin-induced PI3K/AKT/mTOR signaling modulation in BMSC function, and provides actionable protocol guidance for researchers aiming to bridge fundamental mechanistic discovery with workflow optimization in cancer and regenerative medicine. It also highlights how this narrative advances beyond typical product pages by connecting strategic translational needs with rigorous, evidence-backed experimentation.

• Sulfo-NHS-Biotin: Precision Protein Labeling for Cell Profil

  2026-05-14

  Sulfo-NHS-Biotin stands apart as a water-soluble, amine-reactive protein labeling reagent, optimized for selective cell surface biotinylation in high-throughput and single-cell workflows. By leveraging its unique aqueous compatibility, researchers achieve robust, reproducible affinity workflows critical for modern immunology and cell therapy innovation.

• Cy7 NHS Ester: Technical Guidance for Near-Infrared Protein

  2026-05-13

  Cy7 NHS ester addresses the need for efficient, water-soluble, near-infrared labeling of proteins and peptides, particularly in applications requiring minimal denaturation and high imaging sensitivity. It is best used for amino group labeling in workflows that avoid prolonged solution storage or strongly denaturing conditions.

• Sulfo-NHS-SS-Biotin: Precision Protein Labeling for Affinity

  2026-05-13

  Sulfo-NHS-SS-Biotin, a water-soluble, cleavable biotin disulfide N-hydroxysulfosuccinimide ester from APExBIO, enables highly selective and reversible labeling of primary amines on surface proteins. This workflow-driven guide details its distinctive advantages, protocol optimizations, and troubleshooting strategies for robust affinity purification and dynamic interactome analysis.

440 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page